To determine whether AGR2 plays diverse roles in resistant sublines compared to sorafenib-sensitive HCC cells, HepG2 sorafenib-resistant (HepG2-SR) and Huh7 sorafenib-resistant (Huh7-SR) cells were established (Fig. 5A, B). Here, AGR2 is linked to hepatocellular carcinoma.